BOSTON — Despite the unpredictability that comes with new product launches and reimbursement issues, experts are hopeful about ophthalmic business prospects in 2024.
“It is an election year, and that comes with its own uncertainty. I’m sure my colleagues up here will talk a little bit about some of the financial markets and things, but they don’t like uncertainty,” Kristen Harmon Ingenito, MBA, said at Eyecelerator@ASCRS. “We’re keeping our eye on all of that, but we’re optimistic for 2024 and excited to see some of the new products that get